Aurobindo Pharma gets FDA nod for Escitalopram Oxalate

Drug-maker Aurobindo Pharma said it has received tentative approval from the US drug regulator for anti-depressant tablets Escitalopram Oxalate.

Written by Agencies

March 4, 2009 13:16 IST

Drug-maker Aurobindo Pharma said it has received tentative approval from the US drug regulator for anti-depressant tablets Escitalopram Oxalate.

In a filing with the Bombay Stock Exchange, Aurobindo Pharma said it got tentative approval from the US Food and Drug Administration (USFDA) for Escitalopram Oxalate tablets.

Escitalopram Oxalate tablets are the generic version of Forest Laboratories’ Lexapro used in treating patients suffering from depression and mood disorders, it added.

Escitalopram Oxalate tablets will be available in 5 mg, 10 mg and 20 mg.

Aurobindo now has 92 approved Abbreviated New Drug Application (ANDA) from the USFDA.

Shares of the company were trading at Rs 160.40, up 2.79 per cent on the BSE.

This article was first uploaded on March four, twenty nine, at sixteen minutes past one in the afternoon.